top of page

Adding Value to Every Phase of the Life Cycle

We are focused on healthcare related markets, products, services and companies that represent opportunities to grow and develop into market leadership positions through access to operating and capital investment, geographic expansion, and exceptional leadership team support.

BUY IT RIGHT

Utilizing a Structured Approach

Caliburn_Capital_Photo1.jpeg

  • A dedicated team of Lab SMEs​

  • Experience and expertise in lab operations and transactions​

  • Proactive process identifying and engaging preferred assets​

  • Highly fragmented market​

  • Consolidation underway​

  • Strategic buyers publicly reliant on acquisition plans to fuel growth​

CREATING VALUE

Focus on Optimizing Value Creation

Caliburn_Capital_Photo3.jpeg

  • Multiple expansion through critical mass​

  • Regional platform presence​

  • Selectively integrated with functional management teams​

  • Meaningful growth impact transaction for strategic buyers​

  • Growth rate and margin profile accretive to strategic buyers​

RUN IT BETTER

Executing a Disciplined Operating Formula

Caliburn_Capital_Photo2.jpeg

  • Cross segment coverage​

  • Expanded testing offering​

  • Expanded geographic coverage​

  • Salesforce territory revenue growth expansion​

  • Payor contract leverage​

  • Reference lab development​

  • Research depository expansion​

  • Overhead/systems optimization and leverage​

  • Supply chain leverage​

  • Technology Innovation (e.g., Artificial Intelligence and automation)​

Learn More About How Our Approach Is Revolutionizing The Industry

We Employ a Structured Approach to Identify Flagship Portfolio Companies

01

STRATEGIC BUYERS

Strategic Buyers are actively consolidating the regional lab and hospital lab diagnostic markets and relying on M&A activity to add to their organic growth rates*.

03

MARKET EVOLUTION

Market Evolution to include more private equity buyers as has evolved to focus more on treatment and detection of infectious disease**.

02

DIAGNOSTICS

Diagnostics are expected to continue to expand as hospital and other care facilities increasingly outsource testing services and direct to consumer testing increases**.

04

AUTOMATION

Automation along with miniaturization and AI innovation investments are expected to fuel the efficiency and integration of lab services companies that will help attract future investor interest**.

*Quest Company Materials, labcorp Company materials

**Bain and Company: Life Sciences Tools:  Diagnostics Deals on the Rise (3/15/22))

bottom of page